Ryvu Therapeutics S.A. (WSE:RVU)
Poland
· Delayed Price · Currency is PLN 31.60
+0.35 (1.12%)
Jun 27, 2025, 4:45 PM CET
Ryvu Therapeutics Market Cap
Ryvu Therapeutics has a market cap or net worth of 694.76 million as of June 27, 2025. Its market cap has decreased by -44.35% in one year.
Market Cap
694.76M
Enterprise Value
608.88M
Revenue
97.57M
Ranking
n/a
PE Ratio
n/a
Stock Price
31.60
Market Cap Chart
Since July 14, 2011, Ryvu Therapeutics's market cap has increased from 56.50M to 694.76M, an increase of 1,129.59%. That is a compound annual growth rate of 19.68%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NEUCA | 3.08B |
| Synektik Spólka Akcyjna | 1.83B |
| Voxel | 1.62B |
| Celon Pharma | 1.17B |
| Centrum Medyczne ENEL-MED | 554.29M |
| Selvita | 541.49M |
| Bioceltix | 516.08M |
| EMC Instytut Medyczny | 469.52M |